Nuveen Asset Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.19M | Hold |
108,087
| – | – | ﹤0.01% | 2636 |
|
|
2024
Q3 | $1.33M | Sell |
108,087
-79,264
| -42% | -$974K | ﹤0.01% | 2631 |
|
|
2024
Q2 | $2.53M | Buy |
187,351
+67,540
| +56% | +$912K | ﹤0.01% | 2270 |
|
|
2024
Q1 | $1.62M | Buy |
119,811
+56,480
| +89% | +$762K | ﹤0.01% | 2491 |
|
|
2023
Q4 | $333K | Buy |
63,331
+467
| +0.7% | +$2.46K | ﹤0.01% | 3126 |
|
|
2023
Q3 | $248K | Sell |
62,864
-763
| -1% | -$3.01K | ﹤0.01% | 2997 |
|
|
2023
Q2 | $676K | Buy |
63,627
+7,568
| +14% | +$80.4K | ﹤0.01% | 2821 |
|
|
2023
Q1 | $467K | Sell |
56,059
-6,525
| -10% | -$54.4K | ﹤0.01% | 2821 |
|
|
2022
Q4 | $578K | Sell |
62,584
-37,781
| -38% | -$349K | ﹤0.01% | 2848 |
|
|
2022
Q3 | $1.29M | Buy |
100,365
+26,329
| +36% | +$338K | ﹤0.01% | 2629 |
|
|
2022
Q2 | $978K | Buy |
74,036
+16,157
| +28% | +$213K | ﹤0.01% | 2788 |
|
|
2022
Q1 | $1.39M | Buy |
57,879
+722
| +1% | +$17.4K | ﹤0.01% | 2676 |
|
|
2021
Q4 | $1.02M | Sell |
57,157
-4,672
| -8% | -$83.5K | ﹤0.01% | 2856 |
|
|
2021
Q3 | $1.56M | Sell |
61,829
-30,621
| -33% | -$773K | ﹤0.01% | 2790 |
|
|
2021
Q2 | $3.11M | Buy |
92,450
+40,860
| +79% | +$1.38M | ﹤0.01% | 2493 |
|
|
2021
Q1 | $2M | Buy |
51,590
+480
| +0.9% | +$18.6K | ﹤0.01% | 2621 |
|
|
2020
Q4 | $3.17M | Buy |
51,110
+1,145
| +2% | +$70.9K | ﹤0.01% | 2284 |
|
|
2020
Q3 | $1.67M | Sell |
49,965
-6,183
| -11% | -$207K | ﹤0.01% | 2469 |
|
|
2020
Q2 | $1.34M | Sell |
56,148
-29,962
| -35% | -$714K | ﹤0.01% | 2497 |
|
|
2020
Q1 | $1.97M | Buy |
86,110
+64,698
| +302% | +$1.48M | ﹤0.01% | 2198 |
|
|
2019
Q4 | $606K | Sell |
21,412
-1,987
| -8% | -$56.2K | ﹤0.01% | 2860 |
|
|
2019
Q3 | $503K | Buy |
+23,399
| New | +$503K | ﹤0.01% | 2945 |
|